These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 363982)

  • 1. Intraventricular administration of amikacin for complicated Gram-negative meningitis and ventriculitis.
    Wirt TC; McGee ZA; Oldfield EH; Meacham WF
    J Neurosurg; 1979 Jan; 50(1):95-9. PubMed ID: 363982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intraventricular amikacin in the treatment of meningoventriculitis caused by Gram-negative organisms].
    Ludeña Carpio C; Madero López L; Barrio Corrales F; Lozano Jiménez C; Martínez Beltrán J; Loza E
    An Esp Pediatr; 1981 Nov; 15(5):503-6. PubMed ID: 7036809
    [No Abstract]   [Full Text] [Related]  

  • 3. Amikacin therapy of gram-negative bacteremia and meningitis. Treatment in diseases due to multiple resistant bacilli.
    Sklaver AR; Greenman RL; Hoffman TA
    Arch Intern Med; 1978 May; 138(5):713-6. PubMed ID: 348135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual intraventricular plus systemic antibiotic therapy for the treatment of Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae ventriculitis.
    Nevrekar S; Cunningham KC; Greathouse KM; Panos NG
    Ann Pharmacother; 2014 Feb; 48(2):274-8. PubMed ID: 24259634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrathecal amikacin administration. Use in the treatment of gentamicin-resistant Klebsiella pneumoniae meningitis.
    Hamory B; Ignatiadis P; Sande MA
    JAMA; 1976 Oct; 236(17):1973-4. PubMed ID: 787564
    [No Abstract]   [Full Text] [Related]  

  • 6. Outbreak of amikacin-resistant Enterobacteriaceae in an intensive care nursery.
    Cook LN; Davis RS; Stover BH
    Pediatrics; 1980 Feb; 65(2):264-8. PubMed ID: 6986597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacokinetics and efficacy of an aminoglycoside administered into the cerebral ventricles in neonates: implications for further evaluation of this route of therapy in meningitis.
    Wright PF; Kaiser AB; Bowman CM; McKee KT; Trujillo H; McGee ZA
    J Infect Dis; 1981 Feb; 143(2):141-7. PubMed ID: 7012246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of cefotaxime in gram-negative meningitis.
    LeFrock JL; Molavi A; Smith B; Black P; Rosenberg M; Rolston K; Brodner R; Chandrasekar P; Henao L; Kannangara DW
    Neurosurgery; 1984 Nov; 15(5):679-82. PubMed ID: 6095133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotaxime and aminoglycoside treatment of meningitis caused by gram-negative enteric organisms.
    Kaplan SL; Patrick CC
    Pediatr Infect Dis J; 1990 Nov; 9(11):810-4. PubMed ID: 2263430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraventricular CNS treatment with Colistin-Tigecycline combination: A case series.
    Tsolaki V; Karvouniaris M; Manoulakas E; Kotlia P; Karadontas V; Fotakopoulos G; Zakynthinos E; Makris D
    J Crit Care; 2018 Oct; 47():338-341. PubMed ID: 30097260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klebsiella meningitis treated with intrathecal amikacin.
    Block CS; Cassel R; Koornhof HJ; Robinson RG; Lewer-Allen CM
    Lancet; 1977 Jun; 1(8026):1371-2. PubMed ID: 69095
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental infection in rabbits evoked by Pseudomonas aeruginosa, Proteus mirabilis, Escherichia coli and Klebsiella pneumoniae treated with gentamicin, amikacin and sisomicin.
    Jeljaszewicz J; Włodarczak K; Bis W; Kazanowski A; Kuzniewski P; Molska J
    Zentralbl Bakteriol A; 1980 Aug; 247(3):347-52. PubMed ID: 6999802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gram negative bone and joint infection: sixty patients treated with amikacin.
    Schurman DJ; Wheeler R
    Clin Orthop Relat Res; 1978; (134):268-74. PubMed ID: 365414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nosocomial meningitis with dual agents and treatment with intraventricular gentamicin].
    Oztoprak N; Celebi G; Baruönü F; Kalayci M
    Mikrobiyol Bul; 2008 Jul; 42(3):497-501. PubMed ID: 18822895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of an aminoglycoside resistance plasmid by Serratia marcescens during treatment of meningitis with amikacin.
    Rubens CE; McGee ZA; Farrar WE
    J Infect Dis; 1980 Mar; 141(3):346-50. PubMed ID: 6988523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cefotaxime therapy of neonatal gram-negative bacillary meningitis.
    Naqvi SH; Maxwell MA; Dunkle LM
    Pediatr Infect Dis; 1985; 4(5):499-502. PubMed ID: 3900946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraventricular and lumbar intrathecal administration of antibiotics in postneurosurgical patients with meningitis and/or ventriculitis in a serious clinical state.
    Remeš F; Tomáš R; Jindrák V; Vaniš V; Setlík M
    J Neurosurg; 2013 Dec; 119(6):1596-602. PubMed ID: 23952688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin. Clinical and pharmacological studies.
    Holloway WJ
    Int Z Klin Pharmakol Ther Toxikol; 1970 May; 3(2):122-7. PubMed ID: 4913081
    [No Abstract]   [Full Text] [Related]  

  • 19. Gentamicin-resistant bacillary infection. Clinical features and amikacin therapy.
    Leonard JM; McGee ZA; Alford RH
    Arch Intern Med; 1978 Feb; 138(2):201-5. PubMed ID: 415674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with amikacin, a new aminoglycoside antibiotic.
    Theron FP; De Kock MA
    S Afr Med J; 1977 May; 51(21):746-8. PubMed ID: 327583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.